Building Up Skin Models for Numerous Applications - from Two-Dimensional (2D) Monoculture to Three-Dimensional (3D) Multiculture
October 20th, 2023
4.2K views
Here, we present inexpensive and simple procedures to introduce various 3D skin models for routine research in a cell culture laboratory. Researchers can create models tailored to their needs without relying on commercially available models.
Overview
This article presents simple and cost-effective procedures for creating customized 3D skin models in cell culture laboratories. These models can be tailored to specific research needs, providing a more realistic platform for testing ingredients and cytotoxicity.
Key Study Components
Area of Science
- Cell culture
- 3D skin models
- Cytotoxicity testing
Background
- Commercial 3D skin models are limited in cell type diversity.
- Real skin complexity includes various cell types with essential functions.
- 2D cell models lack accuracy in representing real interactions.
- Cost limits the widespread use of commercial 3D models.
Purpose of Study
- To develop affordable and straightforward methods for creating 3D skin models.
- To enable researchers to conduct preliminary experiments on realistic platforms.
- To highlight the importance of using realistic models for ingredient testing.
Methods Used
- Preparation of skin cell suspensions from keratinocytes, fibroblasts, and melanocytes.
- Hanging drop method for creating cell spheres.
- Limiting cell adhesion method for forming stable aggregates.
- Monitoring cell growth and morphology using optical microscopy.
Main Results
- Self-established models can incorporate up to four cell types.
- Limiting cell adhesion methods yield more stable and well-shaped spheres.
- Customized models allow for better representation of skin complexity.
- Models are replicable even by novice researchers.
Conclusions
- Custom 3D skin models provide a cost-effective alternative to commercial options.
- Realistic models are crucial for accurate ingredient testing.
- Simple protocols make these models accessible for routine research.
Frequently Asked Questions
What types of cells are used in the 3D skin models?
The models can include keratinocytes, fibroblasts, melanocytes, and mast cells.
How do the self-established models compare to commercial models?
They offer greater customization and cost-effectiveness, incorporating more cell types.
What methods are used to create the skin models?
The hanging drop method and limiting cell adhesion method are employed.
Can novice researchers replicate these methods?
Yes, the protocols are designed to be accessible and straightforward.
What is the significance of using realistic models?
Realistic models improve the accuracy of ingredient testing and cytotoxicity assessments.
Executive Industry Relevance
Advancing from 2D monoculture to customizable 3D multiculture skin models addresses the need for physiologically relevant, cost-effective platforms in ingredient and cytotoxicity testing. These models enable more predictive early-stage screening and de-risking, especially as regulatory and ethical constraints limit animal testing. Their accessibility and adaptability support broader adoption across discovery and preclinical workflows, enhancing portfolio decision-making.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of compound effects in a tissue-relevant, multicellular context.
- Supports biological de-risking by modeling real skin complexity with up to four cell types.
- Facilitates predictive confidence in early ingredient or drug candidate selection.
Screening & Assay Development
- Provides validated, reproducible 3D systems for quantitative cytotoxicity and ingredient testing.
- Improves assay standardization and scalability compared to commercial or 2D models.
- Enables reliable pre-screening before advancing to certified or regulatory-grade models.
Translational & Preclinical Research
- Aligns in vitro testing with disease-relevant skin architecture for translational continuity.
- Supports risk-adjusted advancement by enabling more accurate preclinical predictions.
- Reduces reliance on animal models, aligning with 3Rs and regulatory trends.
Pipeline & Workflow Integration
These customizable 3D skin models fit from early discovery through preclinical evaluation, bridging the gap between simple cell assays and complex in vivo studies.
- Discovery Biology: Supports hypothesis testing and pathway clarification in a multicellular environment.
- Screening: Delivers reproducible, quantitative outputs for ingredient and cytotoxicity assessment.
- Analytics: Enables comparative analysis of cell viability, morphology, and tissue integrity across conditions.
- Translational Research: Provides a platform for aligning in vitro findings with in vivo relevance.
- Enterprise Reuse: Offers a scalable, adaptable system for repeated use across multiple projects and teams.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in skin-related studies.
- Operational Value: Standardizes workflows and enables reproducibility without specialized equipment.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling early, realistic screening.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of candidates with better biological relevance.
Implementation Considerations
- Requires basic cell culture expertise, accessible to novice and experienced researchers alike.
- Needs standard laboratory equipment; no specialized instrumentation required.
- Demands cross-team standardization for reproducibility and data comparability.
- Adaptable across different cell types and experimental requirements.
- Limitations include manual handling variability and potential for sphere deformation during transfer.
Biopharma FAQs
Why does null hypothesis testing matter for 3D skin model target validation?
Null hypothesis testing in these 3D skin models enables objective assessment of ingredient or compound effects, reducing bias and supporting robust target validation. This approach ensures that observed changes are statistically significant, increasing confidence in early-stage decisions.
How does independent variable isolation fit in multicellular sphere preparation?
Isolating variables such as cell type composition or aggregate size during sphere preparation allows teams to attribute observed effects directly to specific experimental factors. This clarity is essential for mechanistic de-risking and optimizing model design for downstream assays.
What do quantitative dependent variable measurements enable in cytotoxicity testing?
Quantitative readouts, such as cell viability and morphological integrity, provide actionable data for comparing ingredient effects across conditions. These measurements support reproducible screening and facilitate data-driven advancement decisions in the pipeline.
Why are replication requirements critical for cross-functional 3D model use?
Replication ensures that results from 3D skin models are consistent and transferable across teams, supporting collaborative assay development and portfolio-wide data integration. This reliability is vital for enterprise-scale adoption and regulatory alignment.
What statistical analysis capabilities are needed before implementing 3D skin model assays?
Robust statistical tools are required to analyze variability, assess significance, and compare outcomes across experimental groups. These capabilities underpin confident interpretation and support risk-adjusted progression of candidates through the R&D pipeline.
